DA

Deep Apple Therapeutics at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

Deep Apple Therapeutics brings 4 presentations to ObesityWeek 2026 in National Harbor. Its work here centers on early drug discovery for obesity, including oral small molecules that block or activate the GIP receptor and a dual MC4R and MC3R agonist. It also pairs high-throughput cryo-EM with AI foundation models to find amylin receptor drugs.

OrganizationObesityWeek 2026 Attendance
DA
Deep Apple Therapeutics
Biotech
Drug discovery company using cryo-EM and AI to find oral small molecules for obesity targets such as MC4R, GIPR and amylin receptors.
Poster
Sun Nov 15
2:30pm–3:30pm
Poster
Sun Nov 15
2:30pm–3:30pm

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Deep Apple Therapeutics

Tell us what you sell and we’ll find the people at Deep Apple Therapeutics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction